Skip to main content
Clinical Trials/NL-OMON33150
NL-OMON33150
Completed
Not Applicable

Incorporation of Multimodality Magnetic Resonance Imaging in the PRIAS study - MRI value in PRIAS

niversitair Medisch Centrum Sint Radboud0 sites80 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
prostate cancer prostate carcinoma
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
80
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • Histologically proven adenocarcinoma of the prostate
  • PSA \<\= 10 ng/ml and PSA density \<0\.2 ng/ml/ml
  • TRUS\-biopsy Gleason Score \<\= 6 (no 4 or 5 pattern), TRUS\-biopsy
  • characteristics: \< 2 cores involved
  • Clinical stage T1C or T2
  • Appropriate biopsy sampling conform PRIAS study

Exclusion Criteria

  • Patients with known contradictions to MRI
  • Patients with known contra\-indications to Gadolinium based contrast agents.
  • Patients with previous therapy for prostate cancer.
  • Patients who can not or do not want to receive curative treatment in form of radiotherapy or radical prostatectomy
  • Patient request for definitive curative intervention

Outcomes

Primary Outcomes

Not specified

Similar Trials